US$ 20.55
semaglutide approval date GoodRx announced that it will begin selling both of Novo Nordisk's GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at a cash price of $499 per month. The partnership comes Oral Semaglutide Gets FDA Approval
Description
09/27/24 Dupixent (dupilumab) for COPD New indication approval September 27, 2024 - Regeneron and Sanofi announced the approval of a new indication for Dupixent (dupilumab) for chronic obstructive pulmonary disease COPD)

Erratum in Lancet Diabetes Endocrinol

Muscle tissue is metabolically active, burning calories even at rest

doi: 10.1002/cbic.201800346

Balancing caffeine intake is essential for effective weight loss with semaglutide